Voyager Therapeutics, Inc. (VYGR)
3.95
+0.12
(+3.13%)
USD |
NASDAQ |
May 27, 16:00
3.95
0.00 (0.00%)
After-Hours: 20:00
Voyager Therapeutics EPS Diluted (Quarterly) : -0.4696 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biogen, Inc. | 2.153 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
| Savara, Inc. | -0.1472 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -27.94M |
| Revenue (Quarterly) | 2.593M |
| Total Expenses (Quarterly) | 30.53M |
| Enterprise Value | 124.50M |
| Gross Profit Margin (Quarterly) | 64.06% |
| Profit Margin (Quarterly) | -1.08K% |
| Earnings Yield | -50.08% |
| Normalized Earnings Yield | -50.08 |